Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox‐1 homeobox transcription factor

By T. Petrova, Taija Mäkinen, T. Mäkelä, J. Saarela, I. Virtanen, R. Ferrell, D. Finegold, D. Kerjaschki, Seppo Ylä-Herttuala, K. Alitalo. EMBO Journal, 2002

669 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/40ac6e00d66f96e562b80a15f88bc17ec06a66ce

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Rakesh K. Jain
2. N. Ferrara
3. Peter Carmeliet
4. Dai Fukumura
5. K. Alitalo
6. J. Joyce
7. R. Kerbel
8. Lance L. Munn

In Oncology

1. Rakesh K. Jain
2. N. Ferrara
3. Peter Carmeliet
4. K. Alitalo
5. Dai Fukumura
6. Lance L. Munn
7. T. Tammela
8. R. Kerbel

Citations in the corpus

• Consensus guidelines for the use and interpretation of angiogenesis assays (2018, background): “Foreskin-derived human dermal microvascular ECs (HDMECs) or human dermal blood microvascular ECs (HDBECs) are good alternatives; however, the user should be aware that they represent mixed populations of blood and lymphatic endothelial cells [66].”
• Lymphangiogenesis in development and human disease (2005, background): “Accordingly, PROX1 overexpression in human blood vascular endothelial cells suppresses many blood vascular-specific genes and upregulates lymphatic endothelial-cell-specific transcript”